直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

PTAB Shifts 'Midstream,' Puts Unusual End to CBM Review

November 16, 2016

Law360

On November 15, 2016 the Patent Trial and Appeal Board (PTAB) ruled in favor of Finnegan client Securus Technologies, abruptly ending its covered business method (CBM) proceeding after determining that the patent did not relate to a financial product.

Global Tel*Link Corp. and Securus compete in the prison telecommunications space. In May 2015, Global Tel*Link Corp. petitioned for a CBM review of a Securus patent related to call-processing and call-billing technology in used in correctional facilities. From the beginning, Securus argued that the patent was not appropriate for CBM review, as CBM reviews are limited to patents used in financial products or services, and there was no language in any of the patent’s claims that were financial in nature. The PTAB initially disagreed and proceeded with the CBM review, but upon further consideration of the claims, they concluded that the patent did not relate to a financial service.

Tags

telecommunications

Related Practices

專利局受理之無效程序

專利審理暨訴願委員會受理之無效程序: 多方複審及核准後複審

Related Industries

Electrical and Computer Technology

金融服務與商業系統

Related News

Commentary

Early Test of USPTO's Ex Parte Preorder Filing Leads to Re-Exam Denial

August 21, 2026

Award/Ranking

31 Finnegan Attorneys Recognized by Best Lawyers 2027

August 20, 2026

Media Mention

Federal Circuit Backs Volkswagen’s $207,500 Fees Against NPE

August 19, 2026

Commentary

Why Global IP Litigants Keep Turning to English Courts

August 19, 2026

Award/Ranking

Fourteen Finnegan Attorneys Named to the 2026 IAM Strategy 300 List

August 13, 2026

Award/Ranking

Partner Jeffrey M. Jacobstein Named Finalist for New England Legal Awards

August 10, 2026

Commentary

GenAI Patent Surge Extends Well Beyond Familiar Platform Firms

August 10, 2026

Commentary

Q&A: What the 'GenAI Boom' Means for Patents

August 6, 2026

Commentary

U.S. Trademark Owners Turn to "Schedule A" as Blocking Bills Bypass Counterfeiting

August 5, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP